We are live on
!
Find out more
Artisan Partners Portfolio holdings
AUM
$62.3B
1-Year Est. Return
26.25%
This Fund
S&P 500
This Quarter
Est. Return
+9.06%
1 Year Est. Return
+26.25%
3 Year Est. Return
+105.27%
5 Year Est. Return
+134.81%
10 Year Est. Return
+672.1%
AUM
$56.6B
AUM Growth
-$325M
(-0.57%)
Cap. Flow
-$3.6B
Cap. Flow
% of AUM
-6.37%
Top 10 Holdings %
Top 10 Hldgs %
22.76%
Holding
342
New
29
Increased
78
Reduced
210
Closed
22
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$395M |
| 2 |
CoStar Group
CSGP
|
+$241M |
| 3 |
Netflix
NFLX
|
+$149M |
| 4 |
AstraZeneca
AZN
|
+$140M |
| 5 |
Starbucks
SBUX
|
+$127M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$424M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$351M |
| 3 |
Fidelity National Information Services
FIS
|
+$296M |
| 4 |
Ingersoll Rand
IR
|
+$280M |
| 5 |
ON Semiconductor
ON
|
+$253M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 23.46% |
| 2 | Technology | 21.34% |
| 3 | Healthcare | 20.2% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Communication Services | 8.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Freshworks
FRSH
$3.26B
| $20.4M | 0.04% |
1,389,253
-16,309
| -1% | -$226K |
|
252
Axalta
AXTA
$8.05B
| $20.4M | 0.04% |
802,030
-41,256
| -5% | -$1.02M |
|
253
Genmab
GMAB
$19.2B
| $20.4M | 0.04% |
481,853
-509,408
| -51% | -$21M |
|
254
Thermo Fisher Scientific
TMO
$220B
| $20M | 0.04% |
36,233
-282,759
| -89% | -$150M |
|
|
CWAN
255
DELISTED
Clearwater Analytics
CWAN
| $18.9M | 0.03% |
1,005,733
+112,567
| +13% | +$1.95M |
|
256
Establishment Labs
ESTA
$2.26B
| $18.7M | 0.03% |
285,512
-3,957
| -1% | -$239K |
|
257
Cheniere Energy
LNG
$54B
| $18.3M | 0.03% |
122,087
-171,174
| -58% | -$28.6M |
|
258
Freshpet
FRPT
$3.21B
| $18.2M | 0.03% |
344,634
-4,066
| -1% | -$242K |
|
|
EB
259
DELISTED
Eventbrite
EB
| $18.2M | 0.03% |
3,103,436
-36,305
| -1% | -$237K |
|
260
Varex Imaging
VREX
$774M
| $17.8M | 0.03% |
876,632
-844,834
| -49% | -$17.7M |
|
261
Moody's
MCO
$82.8B
| $17.8M | 0.03% |
63,758
-90,472
| -59% | -$24.7M |
|
262
Iovance Biotherapeutics
IOVA
$2.81B
| $17.5M | 0.03% |
2,735,732
-22,841
| -0.8% | -$178K |
|
263
MarketAxess Holdings
MKTX
$5.72B
| $16.4M | 0.03% |
+58,805
| New | +$15.1M |
|
|
CDMO
264
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $15.5M | 0.03% |
1,124,254
-17,612
| -2% | -$270K |
|
|
SGEN
265
DELISTED
Seagen Inc. Common Stock
SGEN
| $15.4M | 0.03% |
120,202
-3,549
| -3% | -$458K |
|
266
Harley-Davidson
HOG
$2.7B
| $15.4M | 0.03% |
370,003
-116,172
| -24% | -$4.95M |
|
|
GTLS
267
DELISTED
Chart Industries
GTLS
| $15.4M | 0.03% |
+133,318
| New | +$21.4M |
|
268
GitLab
GTLB
$6.65B
| $15.1M | 0.03% |
+332,562
| New | +$15M |
|
269
Liberty Broadband Class C
LBRDK
$5.12B
| $13.9M | 0.02% |
182,547
-15,337
| -8% | -$1.25M |
|
|
OLO
270
DELISTED
Olo Inc
OLO
| $13.6M | 0.02% |
2,177,594
-38,538
| -2% | -$291K |
|
|
AKRO
271
DELISTED
Akero Therapeutics
AKRO
| $13.1M | 0.02% |
+238,465
| New | +$10.2M |
|
272
Pinduoduo
PDD
$131B
| $12.9M | 0.02% |
157,870
+9,608
| +6% | +$669K |
|
273
Denali Therapeutics
DNLI
$3.9B
| $12.1M | 0.02% |
435,673
-7,428
| -2% | -$221K |
|
274
STAAR Surgical
STAA
$1.21B
| $11.5M | 0.02% |
236,387
-289,815
| -55% | -$18.2M |
|
275
Credicorp
BAP
$30.8B
| $11.2M | 0.02% |
82,330
-3,817
| -4% | -$541K |
|
Similar funds
Artisan Partners's Q4 2022 Portfolio in Review
As of Q4 2022, Artisan Partners held 342 positions worth $56.6B, down 0.57% from $56.9B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Artisan Partners withdrew a net $3.6B in Q4 2022, closing 22 positions and reducing 210 holdings. Its most notable exit was Fidelity National Information Services, an estimated $296M position sold in full.
By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 22% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Artisan Partners opened a new position in AstraZeneca worth $151M.
- Artisan Partners's largest Q4 2022 buy was AstraZeneca: 1,113,529 shares worth $151M.
- Artisan Partners added most to Zscaler in Q4 2022, an estimated $395M increase.
- Artisan Partners's biggest Q4 2022 reduction was Microsoft, cutting an estimated $424M.
- Artisan Partners fully exited Fidelity National Information Services in Q4 2022, selling an estimated $296M.
- Artisan Partners's ten largest holdings make up 23% of its $56.6B portfolio in Q4 2022.
- Artisan Partners opened 29 new positions and closed 22 in Q4 2022.
- Artisan Partners's portfolio value fell 0.57% quarter-over-quarter to $56.6B.
Based on Artisan Partners's 13F filing for Q4 2022, filed 10 Feb 2023.